Kapake 30mg/500mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Codeine phosphate; Paracetamol

Available from:

Galen Ltd

ATC code:

N02AJ06

INN (International Name):

Codeine phosphate; Paracetamol

Dosage:

30mg ; 500mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

Schedule 5 (CD Inv)

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 04070100; GTIN: 5016298731538 5016298731545

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
KAPAKE 30MG/500MG TABLETS
(Codeine Phosphate and Paracetamol)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Kapake 30mg/500mg Tablets are and what they are used for
2.
What you need to know before you take Kapake 30mg/500mg Tablets
3.
How to take Kapake 30mg/500mg Tablets
4.
Possible side effects
5.
How to store Kapake 30mg/500mg Tablets
6.
Contents of the pack and other information
1.
WHAT KAPAKE 30MG/500MG TABLETS ARE AND WHAT THEY ARE USED FOR
Kapake 30mg/500mg Tablets contain codeine, an opioid analgesic, in
combination with
paracetamol. Kapake 30mg/500mg Tablets are one of a group of medicines
called analgesics or
painkillers. They are used to relieve severe pain in adults.
Codeine can be used in children over 12 years of age for the
short-term relief of moderate pain
that is not relieved by other painkillers such as paracetamol or
ibuprofen alone.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE KAPAKE 30MG/500MG TABLETS
DO NOT TAKE KAPAKE
30MG/500MG
TABLETS:
-
if you are allergic to codeine phosphate, paracetamol or any of the
other ingredients of this
medicine (listed in section 6).
-
if you are suffering from increased pressure on the brain or a head
injury.
-
if you have been told by your doctor that you have a severe breathing
difficulty called
respiratory depression.
-
if you suffer from severe but usually short-lasting asthma attacks
(acute asthma).
-
if you consume excessive amounts of alcohol on a regular basis.
-
if you are taking

Summary of Product characteristics

OBJECT 1
KAPAKE 30MG/500MG TABLETS (CODEINE PHOSPHATE
AND PARACETAMOL)
Summary of Product Characteristics Updated 06-Oct-2017 | Galen Limited
1. Name of the medicinal product
Kapake 30mg/500mg Tablets / Co-Codamol 30mg/500mg Tablets
2. Qualitative and quantitative composition
PER TABLET
Paracetamol
500mg
Codeine Phosphate
30mg
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet.
Oblong, white uncoated tablets marked “Kapake” and bearing a
scoreline on one side, the other side is
plain and unmarked. The score line is only to facilitate breaking for
ease of swallowing and not to divide
into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
For the relief of severe pain in adults.
Codeine is indicated in patients older than 12 years of age for the
treatment of acute moderate pain which
is not considered to be relieved by other analgesics such as
paracetamol or ibuprofen (alone).
4.2 Posology and method of administration
Posology
_Adults:_
One to two tablets every four hours as required.
Maximum of eight tablets daily.
_Paediatric population:_
CHILDREN AGED 12 AND OVER:
One tablet to be taken every six hours as required, up to a maximum of
four tablets in any 24-hour period.
CHILDREN AGED LESS THAN 12 YEARS:
Codeine should not be used in children below the age of 12 years
because of the risk of opioid toxicity
due to the variable and unpredictable metabolism of codeine to
morphine (see sections 4.3 and 4.4).
_Elderly:_
The adult dose is appropriate.
The duration of treatment should be limited to three days and if no
effective pain relief is achieved the
patients/carers should be advised to seek the views of a physician.
Method of administration
For oral use.
4.3 Contraindications
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
This product is contraindicated in patients with raised intracranial
pressure or head injury, respiratory
depression, acute asthma and acute alcoholism.
Kapake/Co-Codamol 30mg/500mg Tablets are also cont